QA: Intra Cellular Therapies Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567514_2023_Intra_Cellular_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567514, Intra Cellular Therapies Inc

  xvar xval
0 AssetsCurrent 737,957,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,913,000
3 remainder_Assets 14,910,000
4 LiabilitiesCurrent 83,236,000
5 LiabilitiesNoncurrent 15,474,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 731,074,303
9 ResearchAndDevelopmentExpense 129,667,432
10 remainder_Expenses 82,425,535
11 remainder_Revenues 1,082,768,244
12 remainder_NetIncome 5,415,000
13 remainder_ComprehensiveNetIncome -11,354,518
  yvar yval
0 Assets 754,780,000
1 Liabilities 98,710,000
2 Expenses 943,167,270
3 Revenues 1,082,768,244
4 StockholdersEquity 656,070,000
5 NetIncome 145,015,974
6 ComprehensiveNetIncome 139,338,715
7 BaseVar 1,448,097,516
8 EconomicCapitalRatiobeforeLimitedLiability 3.68
9 EconomicCapitalRatio 4.16

Edgar->Model Mapping

Feature Distribution

Change over Time